Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes

Biochemical Journal

Volumn 367, Issue 3, 2002, Pages 881-887

  Luiken, J J F P ^a   Willems, J ^a   Coort, S L M ^a   Coumans, W A ^a   Bonen, A ^a   Van der Vusse, G J ^a   Glatz, J F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cellular contractions; Membrane fatty acid transporters; Phosphodiesterase inhibitor; Translocation of fatty acid translocase (FAT) CD36

Indexed keywords

ENZYME INHIBITION; FATTY ACIDS; METABOLISM; MUSCULOSKELETAL SYSTEM;

CELLULAR CONTRACTIONS;

BIOCHEMISTRY;

AMRINONE; BUCLADESINE; CARRIER PROTEIN; CD36 ANTIGEN; CYCLIC AMP DERIVATIVE; CYCLIC GMP; DIPYRIDAMOLE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; LONG CHAIN FATTY ACID; MILRINONE; PALMITIC ACID DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; ZAPRINAST;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MODIFICATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART MUSCLE CELL; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; BUCLADESINE; CYCLIC AMP; ELECTRIC STIMULATION; FATTY ACIDS; HEART; ISOPROTERENOL; MALE; MEMBRANE GLYCOPROTEINS; MYOCARDIUM; ORGANIC ANION TRANSPORTERS; RATS; RATS, INBRED LEW; SUBCELLULAR FRACTIONS;

ANIMALIA;

EID: 0036846035     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020432     Document Type: Article

References (42)

1. Abumrad, N., Coburn, C. and Ibrahimi, A. (1999) Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta 1441, 4-13
2. Luiken, J. J. F. P., Schaap, F. G., van Nieuwenhoven, F. A., van der Vusse, G. J., Bonen, A. and Glatz, J. F. C. (1999) Cellular fatty acid transport in heart as facilitated by proteins. Lipids 34, S169-S175
3. Van Nieuwenhoven, F. A., Willemsen, P. H. M., van der Vusse, G. J. and Glatz, J. F. C. (1999) Co-expression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake. Int. J. Biochem. Cell Biol. 31, 489-498
4. van der Vusse, G. J., van Bilsen, M. and Glatz, J. F. C. (2000) Cardiac fatty acid uptake and transport in health and disease. Cardiovasc. Res. 45, 279-293
5. Bonen, A., Luiken, J. J. F. P., Liu, S., Dyck, D. J., Kiens, B., Kristiansen, S., van der Vusse, G. J. and Glatz, J. F. C. (1998) Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. 275, E471-E478
6. Bonen, A., Luiken, J. J. F. P., Arumugam, Y., Glatz, J. F. C. and Tandon, N. N. (2000) Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 276, 14501-14508
7. Luiken, J. J. F. P., Glatz, J. F. C. and Bonen, A. (2000) Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle. Can. J. Appl. Physiol. 25, 333-351
8. Harmon, C. M., Luce, P., Beth, A. H. and Abumrad, N. A. (1991) Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: Inhibition of fatty acid transport. J. Membr. Biol. 121, 261-268
9. Luiken, J. J. F. P., Turcotte, L. P. and Bonen, A. (1999) Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J. Lipid Res. 40, 1007-1016
10. Luiken, J. J. F. P., Willems, J., van der Vusse, G. J. and Glatz, J. F. C. (2001) Electrical stimulation of cardiac myocytes in suspension increases their rate of uptake of long-chain fatty acids. Am. J. Physiol. 281, E704-E712
11. Ca and Fura-2 transient amplitude in rat myocytes during β-adrenergic stimulation. J. Physiol. (London) 505, 385-402
12. Rose, H., Strotmann, K. H., Pöpping, S., Fischer, Y., Kulsch, D. and Kammermeier, H. (1991) Simultaneous measurement of contraction and oxygen consumption in cardiac myocytes. Am. J. Physiol. 261, H1329-H1334
13. Abdel-Aleem, S. and Frangakis, C. (1991) Stimulation of fatty acid oxidation by phosphodiesterase III inhibitors in rat myocytes. J. Cardiovasc. Pharmacol. 18, 293-297
14. Abdel-Aleem, S., Badr, M. and Frangakis, C. (1991) Stimulation of fatty acid oxidation in myocytes by phosphodiesterase inhibitors and adenosine analogues. Life Sci. 48, PL97-PL102
15. Mills, D. C B. and Smith, J. B. (1971) The influence of platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets. Biochem. J. 121, 185-196
16. Hetman, J. M., Soderling, S. H., Glavas, N. A. and Beavo, J. A. (2000) Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. U.S.A. 97, 472-476
17. Katano, Y. and Endoh, M. (1993) Cyclic AMP metabolism in intact rat ventricular cardiac myocytes: Interaction of carbachol with isoproterenol and 3-isobutyl-1-methylxanthine. Mol. Cell. Biochem. 119, 195-201
18. Howell, R. E., Jenkins, L. P., Fielding, L. E. and Grimes, D. (1995) Inhibition of antigen-induced pulmonary eosinophilia and neutrophilia by selective inhibitors of phosphodiesterase types 3 or 4 in Brown Norway rats. Pulm. Pharmacol. 8, 83-89
19. Gillespie, P. G. and Beavo, J. A. (1989) Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamoleand M&B 22,948. Mol. Pharmacol. 36, 773-781
20. Fischer, Y., Rose, H. and Kammermeier, H. (1991) Highly insulin responsive isolated rat heart muscle cells yielded by a modified isolation method. Life Sci. 49, 1679-1688
21. Luiken, J. J. F. P., van Nieuwenhoven, F. A., America, G., van der Vusse, G. J. and Glatz, J. F. C. (1997) Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. J. Lipid Res. 38, 79-92
22. Fischer, Y., Thomas, J., Rösen, P. and Kammermeier, H. (1995) Action of metformin on glucose transport and glucose transporter GLUT12 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology 136, 412-420
23. Staros, J. V. (1982) N-Hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) of two dicarboxylic esters are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955
24. Bode, D. C., Kanter, J. R. and Brunton, L. L. (1991) Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. Circ. Res. 68, 1070-1079
25. Endoh, M., Yamashita, S. and Taira, N. (1982) Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J. Pharmacol. Exp. Ther. 221, 775-783
26. Endoh, M., Yanagisawa, T., Taira, N. and Blinks, J. R. (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73, III117-III133
27. Kumar, A., Kosuri, R., Kandula, P., Dimou, C., Allen, J. and Parrillo, J. E. (1999) Effects of epinephrine and amrinone on contractility and cyclic adenosinemonophosphate generation of tumor necrosis factor α-exposed cardiac myocytes. Crit. Care Med. 27, 286-292
28. Gong, G. X., Weiss, H. R., Tse, J. and Scholz, P. M. (1997) Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extentunder conditions of increased metabolism. J Cardiovasc. Pharmacol. 30, 537-543
29. Weiss, H. R., Gong, G. X., Straznicka, M., Yan, L., Tse, J. and Scholz, P. M. (1999) Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiacmyocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Can. J. Physiol. Pharmacol. 77, 422-431
30. Abdel-Aleem, S., El-Guindy, N., Sallam, T. I., Hughes, C. and Lowe, J. E. (1998) Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes. J. Cardiovasc. Pharmacol. 33, 43-48
31. Ploug, T., Wojtazewski, J., Kristiansen, S., Hespel, P., Galbo, H. and Richter, E. A. (1993) Glucose transport and transporters in muscle giant vesicles: Differential effects of insulin and contractions. Am. J. Physiol. 264, E270-E278
32. Hatmi, M., Gavaret, J. M., Elalamy, I., Vargaftig, B. B. and Jacquemin, C. (1996) Evidence for cAMP-dependent platelet ectoprotein kinase activity that phosphorylates platelet glycoprotein IV (CD36). J. Biol. Chem. 271, 24776-24780
33. Gibbs, C. L. and Gibson, W. T. (1972) Isoprenaline, propranalol and the energy output of rabbit cardiac muscle. Cardiovasc. Res. 6, 508-515
34. Suga, H., Hisano, R., Goto, Y., Yamada, O. and Igarashi, Y. (1983) Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ. Res. 53, 306-318
35. Von der Leyen, H. (1989) Phosphodiesterase inhibition by new cardiotonic agents: Mechanism of action and possible clinical relevance in the therapy of congestive heart failure. Klin. Wochenschr. 67, 605-615
36. Gutstein, D. E., Flemmal, K., Bruce, E., Travers, K. E., Gwathmey, J. K., Ransil, B. J., Markis, J. E., Grossman, W. and Morgan, J. P. (1996) Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium. J. Card. Failure 2, 285-292
37. Mehra, M. R., Ventura, H, O., Kapoor, C., Stapleton, D. D., Zimmerman, D. and Smart, F. W. (1997) Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am. J. Cardiol. 80, 61-64
38. Cone, J., Wang, S., Tandon, N., Fong, M., Sun, B., Sakurai, K., Yoshitake, M., Kambayashi, J. and Liu, Y. (1999) Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J. Cardiovasc. Pharmacol. 34, 497-504
39. Jiang, Z. Y., Costachescu, T., Derouin, M. and Blaise, G. (2000) Treatment of pulmonary hypertension during surgery with nitric oxide and vasodilators. Can. J. Anaesth. 47, 552-555
40. Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L. et al. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med. 325, 1468-1475
41. Thadani, U. and Roden, D. M. (1998) FDA Panel report: January 1998. Circulation 97, 2295-2296
42. Rodrigues, B., Cam, M. C. and McNeill, J. H. (1998) Metabolic disturbances in diabetic cardiomyopathy. Mol. Cell. Biochem. 180, 53-57